CGM
PFE icon

Capital Growth Management’s Pfizer PFE Stock Holding History

Capital Growth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60,000
Closed -$3.15M – 72
2022
Q2 		$3.15M Buy
+60,000
New +$3.06M 0.37% 60
2020
Q2 		– Sell
-52,700
Closed -$1.63M – 61
2020
Q1 		$1.63M Buy
+52,700
New +$1.8M 0.23% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Growth Management's PFE Position: Q3 2022 in Review

Capital Growth Management sold out of Pfizer (PFE) in Q3 2022, closing a stake of 60,000 shares — an estimated $3.15M sold.

Capital Growth Management first reported a position in PFE in Q1 2020 and held it in 2 quarters. The position peaked at $3.15M in Q2 2022. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Capital Growth Management reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Capital Growth Management sold 60,000 Pfizer shares in Q3 2022, an estimated $3.15M.
  • Capital Growth Management first reported a position in Pfizer in Q1 2020 and held it in 2 quarters.
  • Capital Growth Management's Pfizer position peaked at $3.15M in Q2 2022.
  • 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Capital Growth Management's 13F filing for Q3 2022, filed 14 Nov 2022.